Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.
📚 Books
Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.
Both books are published globally on Amazon (Kindle & Paperback editions available).
🟦 The Mind Game of Trading
Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari
Overview
Trading success is rarely limited by strategy. It is limited by psychology.
In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.
The book focuses on:
• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks
This is not a theory book — it is a practical discipline manual for traders at all levels.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2
🟦 The Stock Market Starter Kit
Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari
Overview
Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.
It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.
It covers:
• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans
Clear. Structured. Actionable.
🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV
-
Semiconductors, EVs, Air India: How N Chandrasekaran Tata Strategy is Pivoting a $300 Billion Empire
N. Chandrasekaran’s extension signals Tata’s most aggressive pivot yet. We decode the Tata’s New Growth Wave in semiconductors, EVs, and aviation, analyzing the high-stakes strategy. Have you ever worked for a massive organization—a company so large and steeped in history that turning its direction feels like trying to steer a freight train? That’s the challenge,…
-
Stocks Near 200 DMA: The Ultimate Long-Term Investing Compass for Indian Markets
Stop chasing short-term noise. Learn the simplest, most powerful long-term trend indicator—the 200-Day Moving Average (200 DMA). Expert strategies for finding quality stocks near 200 DMA. Have you ever felt like the stock market is a chaotic crowd, shouting buy and sell signals at the top of its lungs? One day, your stock is up…
-
TCS Q2 FY26 Results: Revenue Up, $6B Data Center Plan Explained
Imagine running a business the size of TCS, employing over half a million people across the globe. Every quarter, investors, analysts, and employees watch closely—not just for profits, but for signals of growth, transformation, and resilience. TCS’s Q2 FY26 results have just dropped, and they’re packed with insights that matter to anyone tracking Indian IT…
-
“Tata Sons Listing Demand — Inside SP vs Trusts Clash”
“SP Group pushes Tata Sons public listing amid boardroom rift and RBI’s Sep 2025 deadline. Unpack governance clash, minority rights & possible outcomes.” Have you ever seen someone press you from one side while pushing you from the other — and you realize you’re stuck in the tug of dual forces? India’s corporate world is…
-
“India: The New Engine of Global Economic Growth”
India emerges as a global economic powerhouse, with the IMF highlighting its pivotal role amid shifting global growth dynamics. In a world where economic powerhouses like China are experiencing a slowdown, India is stepping up as the new engine of global growth. This shift is not just a statistical anomaly but a testament to India’s…
-
How the U.S. Shelved Tariffs on Generic Drugs — A Lifeline for India’s Pharma
White House shelves tariffs on generic drugs, easing pressure on U.S. patients and Indian pharma exports—insight into impact, risks, and strategy. Imagine walking into a pharmacy tomorrow, only to find your essential medications have suddenly skyrocketed in price. For millions of Americans and healthcare systems worldwide, the threat of tariffs on pharmaceutical imports is more…